Target intelligence / Profile preview

RN7SK pseudogene 21 (RN7SKP21)

Target
RN7SKP21
Molecular classification
Other (Pseudogene, non-coding RNA), not a member of canonical molecular families such as receptors, enzymes, or transcription factors
01

Overview

RN7SK pseudogene 21 (RN7SKP21) is a human pseudogene representing a non-functional copy of the gene encoding 7SK small nuclear RNA, a molecule involved in the regulation of transcription elongation through sequestration of the positive transcription elongation factor P-TEFb[1][3][2][6][4][5]. Unlike its parent gene, RN7SKP21 does not produce a functional RNA, lacks known biological function, is not classified as a therapeutic target, and does not participate in drug interactions or disease processes. RN7SKP21 is one of many 7SK pseudogenes found in the human genome, often arising through duplication events followed by mutation and divergence from the active RN7SK locus. It is primarily of interest in studies of genome architecture and pseudogene evolution, but not in therapeutics or disease biology[2][4][6].

Other names
RNA, 7SK small nuclear pseudogene 21RN7SKP21
02

Mechanism of action

null.

03

Biological functions

None known. Unlike the active 7SK snRNA (which regulates transcription elongation by RNA polymerase II[1][3]), RN7SKP21 lacks demonstrated function.
04

Disease associations

None established. No direct disease association for RN7SKP21. For its parent, 7SK snRNA, aberrations are linked to cancer and immune disease, but this does not extend to the pseudogene.
05

Safety considerations

null. No safety concerns are associated with RN7SKP21; it is not pursued therapeutically.
06

Interacting drugs

None. No drugs interact with RN7SKP21, as it is not an active target.
07

Biomarkers

null. RN7SKP21 is not used as a biomarker for any condition or therapy.

Beyond the preview

Go deeper on RN7SK pseudogene 21 (RN7SKP21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 21 (RN7SKP21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call